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Dear Editor, 
 
Stereotactic surgery represents a highly effective therapy for the treatment of Parkinson's 
disease and other movement disorders refractory to medical treatment. Despite its demonstrated 
safety, some rare adverse events could result in potentially disabling outcomes. Among 
them, hemorrhagic complications (HC) are unarguably the most dangerous and dreaded. In a recent 
systematic survey of the literature, the most important patient-related factors associated with an 
increased risk of HC were age and hypertension, whereas risk factors related to surgical technique 
included the use of intraoperative microelectrode recording (MER), the number of MER 
penetrations, and the sulcal or ventricular involvement by the trajectory[1]. The incidence of HC in 
studies adopting MER was significantly higher than that reported with exclusively image-guided 
approaches[1], [2], [3]. Furthermore, the coexistence of hypertension and MER has been associated to an 
additional rise of bleeding incidence[4]. 
Here we describe a large consecutive series of 221 patients undergoing surgery for Deep Brain 
Stimulation(DBS) lead placement at our institution mainly for advanced Parkinson's disease without 
the occurrence of HC despite the routinely use of intraoperative MER. 
Medical records and postoperative imaging studies of all patients who underwent bilateral DBS lead 
placement at Torino University Hospital between October 1998 and December 2013 were collected. 
A written informed consent was obtained for all participants. The procedures consisted of a single-
session bilateral stereotactic lead implantation[5], performed under local anesthesia by a single 
primary surgeon (ML), using the Cosman–Roberts–Wells stereotactic frame (CRW, Integra 
Radionics, Burlington, MA). Cranial magnetic resonance imaging (MRI)/computed 
tomography (CT) image fusion (Image Fusion, Integra Radionics and I-Plan Stereotaxy, Brainlab 
AG, Feldkirchen, Germany) was used for anatomical targeting, adopting the Schaltenbrand-Wahren 
atlas as a reference[6]. Patients were positioned supine with their head slightly elevated 
(approximately 15°). A 14-mm burr hole was located along the planned trajectory and specific lead-
anchoring systems fixed to the skull (burr-hole ring and cap early in the series; Stimloc, Medtronic, 
Minneapolis, MN, more recently). The dural and pial entry points were coagulated with bipolar 
electrocautery and opened sharply. To minimize the risk of HC, a trajectory avoiding sulci, arteries 
and ventricles was plotted. Intraoperative electrophysiological recording with a single-track MER 
was performed starting from 10 mm above the anatomical target (Microtargeting Electrodes BP, 
FHC Inc., Bowdoin, ME, early in the series, and Neuroprobe™, Alpha Omega, Nazareth, Israel, 
more recently). The electrical signals acquisition was followed by a microelectrode stimulation to 
evaluate both beneficial and side effects, utilizing the MicroGuide Pro™ system (Alpha Omega). 
When MER did not reveal a typical neuronal activity and/or microelectrode stimulation highlighted 
low-threshold side effects, a second or even a third track was performed using the Ben Gun device. 
During the microrecording and stimulation procedure, cerebrospinal fluid loss was minimized by 
flooding the surgical field with saline and sealing the burr hole with oxidized cellulose chips. Expert 
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and trained neurologists examined both beneficial and side effects. Finally, the definitive 
quadripolar electrode (electrode model 3389, Medtronic) was placed along the best trajectory. In 
order to screen for surgical complications, all patients underwent an immediate postoperative CT 
scanfollowed by a cranial MRI 7 days later. In the occurrence of new symptoms suggestive of 
potential neurological complications additional neuroimaging scans were performed. 
As shown in Table 1, a total of 442 quadripolar electrodes (procedures) were implanted in 221 
consecutive patients affected by Parkinson's disease (130 males, 86 females), essential tremor (3 
males) or dystonia (1 male, 1 female). A total of 590 MER tracks were performed (a mean of 1.33 
tracks for each procedure; more than 3 tracks in 4 procedures; 3 tracks in 13 procedures; 2 tracks in 
109 procedures and 1 track in 316 procedures). 
 
Table 1: Demographic and clinical characteristics of 221 patients undergoing placement of DBS 
electrodes utilizing intraoperative MER. 
 
 
Total 
Parkinson's 
disease  
Essential 
tremor Dystonia 
Patients 221 216 3 2 
Electrodes 
implanted 
442 432 6 4 
N
o
 of MER 
tracks 
590 575 7 8 
Gender (M/F) 134/87 
(60.6%/39.4%) 
130/86 
(60.2%/39.8%) 
3/0 
(100%/0%) 
1/1 
(50%/50%) 
Age (years) 60.7 ± 6.9 60.6 ± 6.7 72.7 ± 2.9 25.0 ± 1.0 
Hypertension 42 (19%) 41 (19%) 1 (33.3%) 0 (0%) 
 
Forty-two patients (19%) suffered form hypertension. The mean age at surgery was 60.7 ± 6.9 years 
(males 60.8 ± 6.9; females 60.5 ± 6.9). No HC occurred during both intraoperative and 
postoperative period. 
Hemorrhage is one of the most serious side effects in functional neurosurgery, and it is reported to 
have an overall incidence of up to 5%[1], [2]. In our large series of patients we did not observe any 
HC, even though the population characteristics – in particular age and hypertension percentage – 
were similar to those reported in literature[3], [4]. In all procedures, we routinely performed 
intraoperative electrophysiological monitoring by means of MER, considered a significant bleeding 
risk factor[1], [3], especially if associated with hypertension[4]. These considerations raise the question 
of whether other factors could contribute to the increased risk of HC. 
Indeed, in this series of patients, a thorough trajectory pre-surgical planning, a sequential multiple 
tracks MER, and the application of standardized procedures by an experienced team, probably were 
able to prevent the occurrence of significant hemorrhagic complications. 
In conclusion, we suggest that the use of MER in DBS procedures is not necessarily associated with 
a high risk of HC, given a careful patient selection accompanied by the application of standardized 
surgical procedures by a trained multidisciplinary team. 
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